Madrigal Pharma shares skyrocket 145% on positive results for liver disease therapy By: MarketWatch May 31, 2018 at 13:35 PM EDT NASH, a type of liver disease, is common but has few symptoms, and can seriously harm the liver. Read More >> Related Stocks: Bristol-Myers Squibb Galectin Therapeutic Galmed Pharmaceutica Gilead Sciences Intercept Pharmaceuticals Madrigal Pharmaceuticals Inc Novo Nordisk A/S ADR Viking Thera
